COVID-19 in patients with lung cancerJie Luo, Matthew D. Hellmann, Paul K. Paik et al.|Annals of Oncology|2020Cited by 269
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung CancerJustin F. Gainor, Kylie Prutisto-Chang, Christina J. Falcon et al.|Clinical Cancer Research|2021Cited by 137
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung CancersHelena A. Yu, Mark G. Kris, Yosef Y. Tobi et al.|JAMA Oncology|2020Cited by 131
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J. Choudhury, Helena A. Yu, Christina J. Falcon et al.|Journal of Thoracic Oncology|2022Cited by 95